By targeting the automated workflows around repositories with targeted pull requests, attackers can potentially target ...

Mastra AI’s 144 JavaScript packages was executed in just 88 minutes by North Korea’s Sapphire Sleet hacking group, which ...

The Twitter API is more than just a gateway to tweets; it’s a powerful tool that enables developers to access Twitter data and integrate its functionalities into their applications. This Twitter API ...

Security vendors and their customers have spent considerable time debating where to draw the line between “legitimate” AI agents and “malicious” bots. A 31-day campaign against a major consumer ...

Three LiteLLM flaws let low-privilege users gain admin access and run code, exposing AI keys, secrets, prompts, and responses ...

Integration gives regulated enterprises visibility into Claude activity logs across Claude Enterprise and Claude Platform. Opsin, the AI risk governance platform for regulated enterprises, today ...

AI companies have grown into data-hungry entities as their models require ever-larger datasets to train on. To meet that need, many AI startups defy long-standing internet conventions — like ...

Discover What’s Streaming On: What are we watching tonight, gang? We have the third-season finale of Euphoria on HBO; AFI Life Achievement Award: A Tribute to Eddie Murphy on Netflix; and new episodes ...

Homeland Security Secretary Markwayne Mullin’s proposal could block hubs like Boston, New York and Los Angeles from accepting international flights. By Karoun Demirjian and Madeleine Ngo Reporting ...

After a mid-season break, MGM+'s "From" is back to give us a weekend scare. The teaser for Episode 6 posted on the show's X account shows Boyd's reaction to Jade's plan after his whirlwind mushroom ...

The horror genre is really having a moment right now. Over on Apple TV, Katie Dippold’s absorbing Matthew Rhys-led horror comedy Widow’s Bay is one of the buzziest new shows of the year, and the cult ...

Efficacy and safety of vebreltinib in advanced clear cell sarcoma (VEBrant): A multicenter, phase II study. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not ...